Artemisia para Inflamación crónica
Artemisia koidzumii — 7 estudios científicos revisados
Traditional¿Sirve Artemisia para inflamación crónica?
Los flavonoides y lactonas sesquiterpénicas presentes en especies de Artemisia modulan mediadores inflamatorios como prostaglandinas y citoquinas.
Compuestos activos involucrados: artemisinina, eucaliptol, flavonoides, saponinas, terpenos, lactonas sesquiterpénicas
Evidencia Científica
Los siguientes estudios han investigado la relación entre Artemisia y inflamación crónica:
An ethnobotanical survey on the medicinal and edible plants used by the Daur people in China.
BACKGROUND: The Daur people are one of the 55 minority ethnic groups in China and have lived in Northern China for 300 years. In traditional Daur medicine, medicinal and edible plants (MEPs) are utilised for health benefits and therapeutic purposes; however, related ethnobotanical knowledge is rarely reported, which is disadvantageous for the sustainable development of these MEPs. METHODS: Semi-structured interviews with 122 informants, six focus group discussions, and a resource survey were conducted in a Daur minority nationality area in Inner Mongolia from 2015 to 2020, and the data statist
PubMed: 38790060Ethnobotanical and ethnomedicinal analysis of wild medicinal plants traditionally used in Naâma, southwest Algeria.
Algerian people largely rely on traditional medicine practices as part of a community's identity. This first ethnobotanical study aimed to quantify and document the wild medicinal plant taxa from four family and the related traditional knowledge in Naâma province, Algeria. The survey was carried out between 2018 and 2020. The socio-demographic data and the use of medicinal species were recorded and collected randomly from 84 indigenous people using pre-prepared questionnaire. The result was evaluated using quantitative indices.
PubMed: 34131369Ethnobotanical survey of the traditional antiparasitic use of medicinal plants in humans and animals in Laghouat (Southern Algeria).
BACKGROUND AND AIM: An ethnobotanical survey was carried out among the inhabitants of the Aflou region of Laghouat (Southern Algeria). This study was considered as a first step toward the identification of new bioactive antiparasitic molecules. The preservation and documentation of this traditional knowledge will ensure its continuity and transmission from one generation to another, especially because of the emergence of resistant parasites and the lack of references caused by the lack of work in this area; therefore, we intended to inventory and collect the maximum amount of information on me
PubMed: 37041995Phytochemistry and pharmacological activity of the genus artemisia.
Artemisia and its allied species have been employed for conventional medicine in the Northern temperate regions of North America, Europe, and Asia for the treatments of digestive problems, morning sickness, irregular menstrual cycle, typhoid, epilepsy, renal problems, bronchitis malaria, etc. The multidisciplinary use of artemisia species has various other health benefits that are related to its traditional and modern pharmaceutical perspectives. The main objective of this review is to evaluate the traditional, modern, biological as well as pharmacological use of the essential oil and herbal e
PubMed: 33893998Traditionally used polyherbals in a southern African therapeutic context.
ETHNOPHARMACOLOGICAL RELEVANCE: In African traditional medicine, there are several plant species that are used in combination with either other plant species or non-plant derived combinations such as sugar and honey, salt and vinegar, milk, fat etc. This review examines the role of these combinations and postulates the scientific and therapeutic validation of such combinations. AIM OF THE STUDY: This study reviewed the ethnopharmacological literature and documented the use of southern African plant combinations to find a scientific rationale for such combinations, and provide recommendations f
PubMed: 35017037Seguridad y Precauciones
La seguridad en el uso de Artemisia (Artemisia koidzumii) es un factor crítico que requiere una comprensión profunda de su farmacología. Debido a que la evidencia científica sobre esta especie específica es limitada en comparación con otras especies del género, se deben observar precauciones rigurosas. En el caso de mujeres embarazadas y en periodo de lactancia, el uso de esta planta está estrictamente contraindicado. La literatura científica sobre el género Artemisia indica que dosis elevadas pueden provocar toxicidad reproductiva, lo que implica un riesgo potencial de alteraciones en el desarrollo fetal o complicaciones en el embarazo. No existen estudios que garanticen la ausencia de efectos teratogénicos (malformaciones congénitas) en humanos, por lo que se debe evitar su consumo para proteger la integridad del feto. En niños menores de 12 años, el uso no está recomendado debido a que sus sistemas metabólicos y órganos están en desarrollo; la falta de datos sobre la seguridad pediátrica y el riesgo de neurotoxicidad o alteraciones en el crecimiento hacen que su administración sea altamente riesgosa.\n\nEn cuanto a las interacciones farmacológicas, la complejidad de los metabolitos secundarios de la planta puede alterar la eficacia de medicamentos críticos.
Otras plantas estudiadas para Inflamación crónica
Perfil completo: Ver todos los usos y evidencia de Artemisia →